Baseline resistance associated substitution (RAS) can reduce the efficacy of direct-acting antiviral agents and lead to treatment failure. Clinical data of NS5A RASs prevalence is limited and need to
Crystal structure of a novel dimeric form of HCV NS5A domain I protein Descriptor: GLYCEROL, Non-structural protein 5A, ZINC ION Authors: Love, R.A. Deposit date: 2009-01-07 Release date: 2009-03-10 L
Baseline resistance associated substitution (RAS) can reduce the efficacy of direct-acting antiviral agents and lead to treatment failure. Clinical data of NS5A RASs prevalence is limited and need to
